Best Skin Cancer Treatment in Coimbatore

The skin is the body's most visible organ, and skin cancer is, paradoxically, both the most detectable and the most often underestimated of all cancers. A mole that changes shape, a sore that refuses to heal, a shiny nodule that appears on the face—these are signs that a trained eye can evaluate within minutes. However, in India, people often delay skin cancer presentations due to the dismissal of visible lesions or the stigma associated with seeking evaluation.

At GEM Cancer Centre in Coimbatore, we take skin cancer seriously across the full spectrum from basal cell carcinoma (the most common and most curable) to melanoma (the most dangerous, but increasingly manageable with modern immunotherapy and targeted therapy). Our skin cancer program combines surgical expertise, precision radiation, and access to all approved systemic therapies for advanced melanoma. Patients across Tamil Nadu will find the expertise and technology needed for the best possible outcome.

Types of Skin Cancer

Not all skin cancers are alike. Understanding the type is essential for the right treatment:

• Basal Cell Carcinoma (BCC) is the most common skin cancer globally. Grows slowly, almost never spreads to distant organs, but can invade deeply into underlying tissue if neglected. Highly curable when treated early.
• Squamous Cell Carcinoma (SCC) is more aggressive than BCC with meaningful lymph node spread risk if untreated or in high-risk locations. It is strongly associated with sun exposure, tobacco use, and immunosuppression.
• Melanoma is the most dangerous skin cancer. Arises from melanocytes (pigment-producing cells). Though it is a small fraction of all skin cancers in number, it is responsible for the majority of skin cancer deaths. With immunotherapy and BRAF-targeted therapy, Stage IV melanoma outcomes have been transformed.

Warning Signs—The ABCDE Rule

• A—Asymmetry: One half of the mole does not match the other.
• B—Border: Edges are irregular, ragged, notched, or blurred.
• C—Colour: uneven colouring shades of brown, black, red, white, or blue within a single lesion.
• D—Diameter: larger than 6 mm, though melanomas can be smaller.
• E—Evolution: any change in size, shape, color, or elevation or a new symptom like bleeding or itching.

Diagnosis at GEM Cancer Centre

• Dermatoscopy, a polarized light examination of skin lesions, significantly improves clinical accuracy for distinguishing benign from malignant lesions.
• Excisional or punch biopsy definitive diagnosis requires histopathological tissue examination.
• Sentinel Lymph Node Biopsy (SLNB) for melanoma greater than 1 mm thick; identifies microscopic spread to the first draining lymph node.
• PET-CT staging for high-risk or advanced melanoma detects regional and distant metastases.
• Brain MRI essential for melanoma staging; brain is a common metastatic site and MRI is far more sensitive than CT.
• BRAF V600E mutation testing performed on all metastatic melanoma samples; determines targeted therapy eligibility.
• PD-L1 and tumour mutational burden (TMB) guides immunotherapy selection.

Treatment Options at GEM Cancer Centre

Surgical Excision & Wide Local Excision (WLE)

The cornerstone of treatment for all primary skin cancers is surgical excision with adequate margins. For melanoma, margins of 1–2 cm are recommended depending on Breslow thickness. GEM Cancer Centre's surgical oncologists perform primary closure, local flaps, and skin grafting as needed, achieving both oncological clearance and optimal cosmetic outcomes for face and scalp lesions.

Radiation Therapy

Radiation therapy via our TrueBeam system delivers precise treatment with excellent local control rates for skin cancers located in cosmetically sensitive areas (eyelid, nasal tip, ear, lip) where surgery would compromise function, or for patients who are unable to undergo surgery.

Immunotherapy for Advanced Melanoma

Pembrolizumab (anti-PD1) achieves objective responses in 30–40% of metastatic melanoma patients, with 5-year survival rates of 30–34% compared to less than 10% with prior-era chemotherapy. The combination of ipilimumab (anti-CTLA4) plus nivolumab achieves even higher response rates of 55–60% in selected patients.

Targeted Therapy: BRAF and MEK Inhibitors

For the 50% of melanomas carrying the BRAF V600E mutation, the combination of a BRAF inhibitor (dabrafenib or vemurafenib) and a MEK inhibitor (trametinib or cobimetinib) achieves rapid tumor shrinkage in over 70% of patients.

Adjuvant Immunotherapy for High-Risk Resected Melanoma

Patients with stage III melanoma benefit significantly from 12 months of adjuvant pembrolizumab or nivolumab after surgery, reducing recurrence risk by approximately 35% compared to observation alone.

Why Choose GEM Cancer Centre?

• Dermatologic oncology expertise in the full spectrum from excision to systemic therapy.
• BRAF, PD-L1, and TMB in-house molecular testing guide personalized treatment.
• TrueBeam radiation for inoperable or high-risk skin cancers requiring radiotherapy.
• Access to all approved immunotherapy and targeted therapy agents for advanced melanoma.
• Skin cancer tumour board surgical, radiation, and medical oncology review.
• Coimbatore's first standalone cancer hospital dedicated cancer expertise

When to See a Doctor

Any lesion on your skin that changes, bleeds, itches, or fails to heal deserves evaluation. Don't apply home remedies to a changing mole. Don't wait to see if it improves. At GEM Cancer Centre in Coimbatore, a skin cancer consultation is quick, minimally invasive, and potentially life-saving. If you are immunosuppressed, have a personal or family history of melanoma, or work outdoors extensively, annual skin checks are recommended.

Frequently Asked Questions

Does darker skin protect against skin cancer?

Higher melanin content in darker skin provides more natural UV protection and reduces the incidence of UV-related BCC and SCC. However, melanoma in darker-skinned individuals often presents in non-sun-exposed sites (palms, soles, and under nails) and is frequently diagnosed late due to lower clinical suspicion. Any pigmented lesion in these locations warrants prompt evaluation.

What is the difference between immunotherapy and targeted therapy for melanoma?

Immunotherapy (anti-PD1, anti-CTLA4) functions by enabling the immune system to target cancer cells across the body. It works regardless of BRAF mutation status and can produce durable long-term responses. Targeted therapy (BRAF+MEK inhibitors) works only in BRAF-mutated melanoma, acts faster, but is associated with acquired resistance over time.

Can a mole be safely removed if I am worried about it?

Yes. Any suspicious mole can be excised under local anesthesia as a minor outpatient procedure and sent for pathological examination. If it turns out to be benign, perfect. If there is melanoma, you will have caught it early. GEM Cancer Centre performs same-day suspicious mole excisions with pathology results available within 5–7 days.

Is basal cell carcinoma life-threatening?

Standard BCC, when treated promptly, is almost never life-threatening; it has an extremely low rate of spread to other organs. However, neglected BCC can invade deeply, destroying underlying tissue, cartilage, and bone around the nose, eyes, and ears. Early treatment prevents these complications entirely.

How long does immunotherapy for melanoma continue?

Standard pembrolizumab or nivolumab is given intravenously every 3–6 weeks for up to 2 years in the metastatic setting, or 12 months in the adjuvant setting. Treatment may be stopped earlier if the patient achieves complete remission or experiences significant immune-related side effects. GEM Cancer Centre monitors all patients closely.

What is the best skin cancer treatment in Coimbatore?

GEM Cancer Centre offers wide local excision, TrueBeam radiation therapy, and advanced systemic therapy, including immunotherapy (pembrolizumab, nivolumab, and ipilimumab) and BRAF/MEK targeted therapy for all skin cancer types, including advanced melanoma.